This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

MorphoSys Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:MPSY.F Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Aug 24	BuyUS$90,646,256	Novartis AG	Company	1,216,926	US$74.49
16 Jun 24	BuyUS$46,647,244	Novartis AG	Company	641,331	US$72.74
10 Jun 24	BuyUS$272,172,775	Novartis AG	Company	3,725,565	US$73.06
23 May 24	BuyUS$1,884,982,446	Novartis AG	Company	25,610,813	US$73.60
16 Apr 24	BuyUS$314,955,281	Novartis AG	Company	4,360,100	US$72.25

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MPSY.F?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	215,483	0.351%
Individual Insiders	988,318	1.61%
Hedge Funds	1,890,000	3.07%
Institutions	22,775,114	37%
Public Companies	35,608,420	57.9%

Dilution of Shares: Insufficient data to determine if shareholders have been diluted in the past year.

Top Shareholders

Top 25 shareholders own 161.53% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
94.6%	Novartis AG	35,608,420	US$2.6b	3.7%	no data
8.62%	T. Rowe Price Group, Inc.	3,245,202	US$241.0m	0%	0.02%
5.02%	Adage Capital Management, L.P.	1,890,000	US$140.3m	0%	0.25%
4.59%	Susquehanna International Group, LLP, Asset Management Arm	1,730,234	US$128.5m	-2.05%	0.22%
4.54%	BNP Paribas Securities Corp, Asset Management Arm	1,711,331	US$127.1m	0%	2.95%
4.27%	JPMorgan Chase & Co, Brokerage and Securities Investments	1,607,684	US$119.4m	-14.6%	0.06%
3.55%	Rp Management, Llc, Asset Management Arm	1,337,552	US$99.3m	0%	27.86%
3.45%	Barclays Bank PLC, Securities Investments	1,299,717	US$96.5m	-11.3%	0.11%
3.17%	Merrill Lynch & Co. Inc., Banking Investments	1,192,607	US$88.6m	0%	0.03%
2.88%	Goldman Sachs Group, Investment Banking and Securities Investments	1,084,624	US$80.5m	189%	0.04%
2.68%	Artisan Partners Limited Partnership	1,010,913	US$75.1m	0%	0.06%
2.6%	Invesco Ltd.	979,174	US$72.7m	0%	0.02%
2.59%	Wendy Johnson	975,441	US$72.4m	0%	no data
2.46%	FMR LLC	927,821	US$68.9m	0%	no data
2.43%	Bank of America Corporation, Asset Management Arm	916,229	US$68.0m	-0.09%	0.02%
2.3%	Deutsche Asset & Wealth Management	868,004	US$64.5m	30.8%	0.02%
2.22%	Baillie Gifford & Co.	835,292	US$62.0m	0%	0.03%
1.78%	BlackRock, Inc.	670,069	US$49.8m	-27.5%	no data
1.76%	Morgan Stanley, Investment Banking and Brokerage Investments	662,317	US$49.2m	-0.01%	0.01%
1.68%	UBS Asset Management AG	634,465	US$47.1m	-0.13%	no data
1.16%	Barclays Bank PLC, Wealth and Investment Management Division	436,327	US$32.4m	0%	0.3%
0.98%	Norges Bank Investment Management	370,484	US$27.5m	-56.9%	no data
0.77%	JPMorgan Chase & Co, Private Banking and Investment Banking Investments	289,931	US$21.5m	-61.7%	0.01%
0.74%	Candriam	279,727	US$20.8m	0%	0.05%
0.73%	Union Asset Management Holding AG	274,044	US$20.3m	0%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/10/06 22:35
End of Day Share Price	2024/07/09 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MorphoSys AG is covered by 35 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Olav Zilian	Baader Helvea Equity Research
Brian Balchin	Barclays
Rosie Turner	Barclays